Document is current
Any future updates will be listed below
-
Authors
Kuroda, Makoto
Halfmann, Peter J. https://orcid.org/0000-0002-1648-1625
Uraki, Ryuta https://orcid.org/0000-0003-0890-1922
Yamayoshi, Seiya https://orcid.org/0000-0001-7768-5157
Kim, Taksoo
Armbrust, Tammy A.
Spyra, Sam
Dahn, Randall
Babujee, Lavanya
Kawaoka, Yoshihiro https://orcid.org/0000-0001-5061-8296
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (P01AI165077)
Japan Agency for Medical Research and Development (JP23wm0125002, JP233fa627001, JP233fa827005)
- License Information
-
More Information
Article History
Received: 7 October 2023
Accepted: 25 April 2025
First Online: 14 May 2025
Competing interests
: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio. The other authors declare that they have no competing interests.
